Literature DB >> 22869745

Total kinetic analysis reveals how combinatorial methylation patterns are established on lysines 27 and 36 of histone H3.

Yupeng Zheng1, Steve M M Sweet, Relja Popovic, Eva Martinez-Garcia, Jeremiah D Tipton, Paul M Thomas, Jonathan D Licht, Neil L Kelleher.   

Abstract

We have developed a targeted method to quantify all combinations of methylation on an H3 peptide containing lysines 27 and 36 (H3K27-K36). By using stable isotopes that separately label the histone backbone and its methylations, we tracked the rates of methylation and demethylation in myeloma cells expressing high vs. low levels of the methyltransferase MMSET/WHSC1/NSD2. Following quantification of 99 labeled H3K27-K36 methylation states across time, a kinetic model converged to yield 44 effective rate constants qualifying each methylation and demethylation step as a function of the methylation state on the neighboring lysine. We call this approach MS-based measurement and modeling of histone methylation kinetics (M4K). M4K revealed that, when dimethylation states are reached on H3K27 or H3K36, rates of further methylation on the other site are reduced as much as 100-fold. Overall, cells with high MMSET have as much as 33-fold increases in the effective rate constants for formation of H3K36 mono- and dimethylation. At H3K27, cells with high MMSET have elevated formation of K27me1, but even higher increases in the effective rate constants for its reversal by demethylation. These quantitative studies lay bare a bidirectional antagonism between H3K27 and H3K36 that controls the writing and erasing of these methylation marks. Additionally, the integrated kinetic model was used to correctly predict observed abundances of H3K27-K36 methylation states within 5% of that actually established in perturbed cells. Such predictive power for how histone methylations are established should have major value as this family of methyltransferases matures as drug targets.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22869745      PMCID: PMC3427122          DOI: 10.1073/pnas.1205707109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas.

Authors:  Christopher J Sneeringer; Margaret Porter Scott; Kevin W Kuntz; Sarah K Knutson; Roy M Pollock; Victoria M Richon; Robert A Copeland
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-15       Impact factor: 11.205

2.  Chemical derivatization of histones for facilitated analysis by mass spectrometry.

Authors:  Benjamin A Garcia; Sahana Mollah; Beatrix M Ueberheide; Scott A Busby; Tara L Muratore; Jeffrey Shabanowitz; Donald F Hunt
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

3.  Pervasive combinatorial modification of histone H3 in human cells.

Authors:  Benjamin A Garcia; James J Pesavento; Craig A Mizzen; Neil L Kelleher
Journal:  Nat Methods       Date:  2007-05-21       Impact factor: 28.547

Review 4.  Mechanisms of epigenetic inheritance.

Authors:  Cyrus Martin; Yi Zhang
Journal:  Curr Opin Cell Biol       Date:  2007-04-26       Impact factor: 8.382

5.  Combinatorial patterns of histone acetylations and methylations in the human genome.

Authors:  Zhibin Wang; Chongzhi Zang; Jeffrey A Rosenfeld; Dustin E Schones; Artem Barski; Suresh Cuddapah; Kairong Cui; Tae-Young Roh; Weiqun Peng; Michael Q Zhang; Keji Zhao
Journal:  Nat Genet       Date:  2008-06-15       Impact factor: 38.330

6.  H3K36 methylation antagonizes PRC2-mediated H3K27 methylation.

Authors:  Wen Yuan; Mo Xu; Chang Huang; Nan Liu; She Chen; Bing Zhu
Journal:  J Biol Chem       Date:  2011-01-14       Impact factor: 5.157

7.  NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming.

Authors:  Alex J Kuo; Peggie Cheung; Kaifu Chen; Barry M Zee; Mitomu Kioi; Josh Lauring; Yuanxin Xi; Ben Ho Park; Xiaobing Shi; Benjamin A Garcia; Wei Li; Or Gozani
Journal:  Mol Cell       Date:  2011-11-18       Impact factor: 17.970

8.  Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27).

Authors:  Michael T McCabe; Alan P Graves; Gopinath Ganji; Elsie Diaz; Wendy S Halsey; Yong Jiang; Kimberly N Smitheman; Heidi M Ott; Melissa B Pappalardi; Kimberly E Allen; Stephanie B Chen; Anthony Della Pietra; Edward Dul; Ashley M Hughes; Seth A Gilbert; Sara H Thrall; Peter J Tummino; Ryan G Kruger; Martin Brandt; Benjamin Schwartz; Caretha L Creasy
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-08       Impact factor: 11.205

9.  The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor.

Authors:  Jotin Marango; Manabu Shimoyama; Hitomi Nishio; Julia A Meyer; Dong-Joon Min; Andres Sirulnik; Yolanda Martinez-Martinez; Marta Chesi; P Leif Bergsagel; Ming-Ming Zhou; Samuel Waxman; Boris A Leibovitch; Martin J Walsh; Jonathan D Licht
Journal:  Blood       Date:  2007-12-21       Impact factor: 22.113

10.  Global turnover of histone post-translational modifications and variants in human cells.

Authors:  Barry M Zee; Rebecca S Levin; Peter A DiMaggio; Benjamin A Garcia
Journal:  Epigenetics Chromatin       Date:  2010-12-06       Impact factor: 4.954

View more
  63 in total

Review 1.  Histone methyltransferases: novel targets for tumor and developmental defects.

Authors:  Xin Yi; Xue-Jun Jiang; Xiao-Yan Li; Ding-Sheng Jiang
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

2.  Unabridged Analysis of Human Histone H3 by Differential Top-Down Mass Spectrometry Reveals Hypermethylated Proteoforms from MMSET/NSD2 Overexpression.

Authors:  Yupeng Zheng; Luca Fornelli; Philip D Compton; Seema Sharma; Jesse Canterbury; Christopher Mullen; Vlad Zabrouskov; Ryan T Fellers; Paul M Thomas; Jonathan D Licht; Michael W Senko; Neil L Kelleher
Journal:  Mol Cell Proteomics       Date:  2015-08-13       Impact factor: 5.911

Review 3.  The Role of Nuclear Receptor-Binding SET Domain Family Histone Lysine Methyltransferases in Cancer.

Authors:  Richard L Bennett; Alok Swaroop; Catalina Troche; Jonathan D Licht
Journal:  Cold Spring Harb Perspect Med       Date:  2017-06-01       Impact factor: 6.915

4.  Drawbacks in the use of unconventional hydrophobic anhydrides for histone derivatization in bottom-up proteomics PTM analysis.

Authors:  Simone Sidoli; Zuo-Fei Yuan; Shu Lin; Kelly Karch; Xiaoshi Wang; Natarajan Bhanu; Anna M Arnaudo; Laura-Mae Britton; Xing-Jun Cao; Michelle Gonzales-Cope; Yumiao Han; Shichong Liu; Rosalynn C Molden; Samuel Wein; Leila Afjehi-Sadat; Benjamin A Garcia
Journal:  Proteomics       Date:  2015-05       Impact factor: 3.984

Review 5.  Molecular pathways: deregulation of histone h3 lysine 27 methylation in cancer-different paths, same destination.

Authors:  Teresa Ezponda; Jonathan D Licht
Journal:  Clin Cancer Res       Date:  2014-07-01       Impact factor: 12.531

Review 6.  Quantitative proteomic analysis of histone modifications.

Authors:  He Huang; Shu Lin; Benjamin A Garcia; Yingming Zhao
Journal:  Chem Rev       Date:  2015-02-17       Impact factor: 60.622

7.  Phosphorylation-mediated EZH2 inactivation promotes drug resistance in multiple myeloma.

Authors:  Jiro Kikuchi; Daisuke Koyama; Taeko Wada; Tohru Izumi; Peter O Hofgaard; Bjarne Bogen; Yusuke Furukawa
Journal:  J Clin Invest       Date:  2015-10-26       Impact factor: 14.808

8.  A clinically relevant murine model unmasks a "two-hit" mechanism for reactivation and dissemination of cytomegalovirus after kidney transplant.

Authors:  Zheng Zhang; Longhui Qiu; Shixian Yan; Jiao-Jing Wang; Paul M Thomas; Manoj Kandpal; Lihui Zhao; Andre Iovane; Xue-Feng Liu; Edward B Thorp; Qing Chen; Mary Hummel; Yashpal S Kanwar; Michael M Abecassis
Journal:  Am J Transplant       Date:  2019-05-14       Impact factor: 8.086

9.  Stable-isotope-labeled histone peptide library for histone post-translational modification and variant quantification by mass spectrometry.

Authors:  Shu Lin; Samuel Wein; Michelle Gonzales-Cope; Gabriel L Otte; Zuo-Fei Yuan; Leila Afjehi-Sadat; Tobias Maile; Shelley L Berger; John Rush; Jennie R Lill; David Arnott; Benjamin A Garcia
Journal:  Mol Cell Proteomics       Date:  2014-07-07       Impact factor: 5.911

Review 10.  H3K27 Methylation: A Focal Point of Epigenetic Deregulation in Cancer.

Authors:  J N Nichol; D Dupéré-Richer; T Ezponda; J D Licht; W H Miller
Journal:  Adv Cancer Res       Date:  2016-06-17       Impact factor: 6.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.